Ipswich Investment Management Co. Inc. Has $1.67 Million Holdings in Danaher Co. (NYSE:DHR)

Ipswich Investment Management Co. Inc. raised its position in Danaher Co. (NYSE:DHR) by 1.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,008 shares of the conglomerate’s stock after purchasing an additional 82 shares during the quarter. Ipswich Investment Management Co. Inc.’s holdings in Danaher were worth $1,670,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. acquired a new position in Danaher during the 2nd quarter worth approximately $25,000. nVerses Capital LLC acquired a new position in Danaher during the second quarter worth $25,000. MFA Wealth Advisors LLC bought a new position in Danaher in the second quarter valued at $51,000. Financial Connections Group Inc. acquired a new stake in Danaher in the 2nd quarter valued at $51,000. Finally, Western Pacific Wealth Management LP bought a new stake in Danaher during the 1st quarter worth about $55,000. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

DHR has been the topic of a number of recent research reports. Wells Fargo & Company began coverage on Danaher in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 target price on the stock. Royal Bank of Canada dropped their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a research note on Thursday, October 31st. Leerink Partners boosted their price objective on shares of Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Finally, KeyCorp boosted their price target on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Stock Down 3.7 %

NYSE DHR opened at $230.51 on Friday. The company has a market cap of $166.49 billion, a price-to-earnings ratio of 43.99, a PEG ratio of 4.44 and a beta of 0.85. Danaher Co. has a 1-year low of $206.30 and a 1-year high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a 50 day moving average of $262.20 and a 200-day moving average of $260.38.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the prior year, the business earned $2.02 earnings per share. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. On average, equities research analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Insider Activity

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 18.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.